CLAIM #36556 · Eli Lilly and Company (LLY) · 2022Q1 earnings call · Apr 28, 2022 · due Apr 28, 2024
“We do expect that we show good outcomes there that for those people who have obesity and sleep apnea that we should be able to gain access for it.”
Mike B Mason · President, Lilly Diabetes
CANNOT_DETERMINE
versus commitment · official band 5 percent
Committed
We do expect that we show good outcomes there that for those people who have obesity and sleep apnea that we should be able to gain access for it.
Reported
we actually expect to get obstructive sleep apnea for Zepbound covered by CMS and Medicare at the time of launch.
Verify independently
SEC filings for LLY ↗ · Claim quote is verbatim from the 2022Q1 earnings call.